The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Diğer sürümleri göster (1)

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

Detaylı Bibliyografya
Asıl Yazarlar:	Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	Springer London 2018

Benzer Materyaller

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
Yazar:: Ali, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
Yazar:: Ali, MS, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Oral bisphosphonates and chronic kidney disease: progression and safety
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
Yazar:: Alarkawi, D, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
Yazar:: Robinson, DE, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
Yazar:: Strauss, V, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Yazar:: Robinson, DE, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Yazar:: Robinson, DE, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
Yazar:: Alarkawi, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
Yazar:: Ali, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
Yazar:: Danielle E Robinson, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
Yazar:: Veronika Kreutle, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
Yazar:: Hawley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
Yazar:: Ryan Jalleh, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Denosumab and chronic kidney disease: Severe life-threatening hypocalcaemia
Yazar:: Pilar Monge Rafael, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
Yazar:: Ali, MS, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
Yazar:: Abrahamsen, B, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
Yazar:: Oda, T, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
Yazar:: Round, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
Yazar:: Round, G, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
Yazar:: Reyes, C, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
Yazar:: Jean-Jacques Body, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
Yazar:: Rodriguez, AJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
Yazar:: Garriga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
Yazar:: Garriga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
Yazar:: Garriga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
Yazar:: Garriga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Vitamin D repletion and aromatase inhibitor-related bone loss in women non treated with bisphosphonates
Yazar:: Prieto-Alhambra, D, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
Yazar:: Khalid, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

HYPOCALCAEMIA – CASE REPORT
Yazar:: Tina Svetlik, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Pseudohypoparathyroidism, Rare Cause of Hypocalcaemia!
Yazar:: Rupal V. Dosi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-10-01)